期刊文献+

生血宁片联合促红细胞生成素(EPO)治疗肾性贫血的临床观察 被引量:9

Clinical Observation on Shengxuening Tablets Combined With Erythropoietin(EPO) in the Treatment of Renal Anemia
下载PDF
导出
摘要 目的探究肾性贫血患者采用生血宁片和促红细胞生成素综合治疗的效果。方法选取2014年1月~2015年3月收治的76例肾性贫血患者进行治疗,随机分为对照组和实验组,比较治疗后身体指标的改善。结果实验组患者治疗有效率为95.35%,对照组患者治疗有效率为78.79%,实验组患者的治疗效果优于对照组,差异有统计学意义(P〈0.05)。结论肾性贫血患者采用生血宁片和促红细胞生成素综合治疗,可延长红细胞的寿命,改善贫血症状,提高生活质量。 Objective To explore treatment effect of the patients with renal anemia by Shengxuening and erythropoietin. Methods 76 patients with renal anemia treated in our hospital from January 2014 to March 2015 were slected,the improvement of the physical index was compared. Results 95.35% of the patients in the experimental group were treated with efficiency,and the control group was treated with 78.79%. The treatment effect of the experimental group was more significant,and it was statistically significant(P 0.05). Conclusion In patients with renal anemia by Shengxuening tablets and erythropoietin therapy,can prolong the life of red blood cells,improve the symptoms of anemia,and improve the quality of life.
机构地区 郑州市中医院
出处 《中国卫生标准管理》 2015年第21期105-106,共2页 China Health Standard Management
基金 河南省科技攻关项目(142102310166)
关键词 肾性贫血患者 生血宁片 促红细胞生成素 Renal anemia Shengxuening tablets Erythropoietin
  • 相关文献

参考文献3

二级参考文献15

共引文献24

同被引文献102

引证文献9

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部